| Analysis | Samples | Factors | Units |
|---|---|---|---|
| HILIC POSITIVE ION MODE | tumor-enzalutamide-1-01 | Treatment:Enzalutamide | Technical Replicate (Region of Tumor):1 | Peak Area |
| HILIC POSITIVE ION MODE | tumor-enzalutamide-2-01 | Treatment:Enzalutamide | Technical Replicate (Region of Tumor):1 | Peak Area |
| HILIC POSITIVE ION MODE | tumor-enzalutamide-3-01 | Treatment:Enzalutamide | Technical Replicate (Region of Tumor):1 | Peak Area |
| HILIC POSITIVE ION MODE | tumor-enzalutamide-4-01 | Treatment:Enzalutamide | Technical Replicate (Region of Tumor):1 | Peak Area |
| HILIC POSITIVE ION MODE | tumor-enzalutamide-5-01 | Treatment:Enzalutamide | Technical Replicate (Region of Tumor):1 | Peak Area |
| HILIC POSITIVE ION MODE | tumor-enzalutamide-1-02 | Treatment:Enzalutamide | Technical Replicate (Region of Tumor):2 | Peak Area |
| HILIC POSITIVE ION MODE | tumor-enzalutamide-2-02 | Treatment:Enzalutamide | Technical Replicate (Region of Tumor):2 | Peak Area |
| HILIC POSITIVE ION MODE | tumor-enzalutamide-3-02 | Treatment:Enzalutamide | Technical Replicate (Region of Tumor):2 | Peak Area |
| HILIC POSITIVE ION MODE | tumor-enzalutamide-4-02 | Treatment:Enzalutamide | Technical Replicate (Region of Tumor):2 | Peak Area |
| HILIC POSITIVE ION MODE | tumor-enzalutamide-5-02 | Treatment:Enzalutamide | Technical Replicate (Region of Tumor):2 | Peak Area |
| HILIC POSITIVE ION MODE | tumor-veh-1-01 | Treatment:Vehicle | Technical Replicate (Region of Tumor):1 | Peak Area |
| HILIC POSITIVE ION MODE | tumor-veh-2-01 | Treatment:Vehicle | Technical Replicate (Region of Tumor):1 | Peak Area |
| HILIC POSITIVE ION MODE | tumor-veh-3-01 | Treatment:Vehicle | Technical Replicate (Region of Tumor):1 | Peak Area |
| HILIC POSITIVE ION MODE | tumor-veh-1-02 | Treatment:Vehicle | Technical Replicate (Region of Tumor):2 | Peak Area |
| HILIC POSITIVE ION MODE | tumor-veh-2-02 | Treatment:Vehicle | Technical Replicate (Region of Tumor):2 | Peak Area |
| HILIC POSITIVE ION MODE | tumor-veh-3-02 | Treatment:Vehicle | Technical Replicate (Region of Tumor):2 | Peak Area |
| HILIC NEGATIVE ION MODE | tumor-enzalutamide-1-01 | Treatment:Enzalutamide | Technical Replicate (Region of Tumor):1 | Peak Area |
| HILIC NEGATIVE ION MODE | tumor-enzalutamide-2-01 | Treatment:Enzalutamide | Technical Replicate (Region of Tumor):1 | Peak Area |
| HILIC NEGATIVE ION MODE | tumor-enzalutamide-3-01 | Treatment:Enzalutamide | Technical Replicate (Region of Tumor):1 | Peak Area |
| HILIC NEGATIVE ION MODE | tumor-enzalutamide-4-01 | Treatment:Enzalutamide | Technical Replicate (Region of Tumor):1 | Peak Area |
| HILIC NEGATIVE ION MODE | tumor-enzalutamide-5-01 | Treatment:Enzalutamide | Technical Replicate (Region of Tumor):1 | Peak Area |
| HILIC NEGATIVE ION MODE | tumor-enzalutamide-1-02 | Treatment:Enzalutamide | Technical Replicate (Region of Tumor):2 | Peak Area |
| HILIC NEGATIVE ION MODE | tumor-enzalutamide-2-02 | Treatment:Enzalutamide | Technical Replicate (Region of Tumor):2 | Peak Area |
| HILIC NEGATIVE ION MODE | tumor-enzalutamide-3-02 | Treatment:Enzalutamide | Technical Replicate (Region of Tumor):2 | Peak Area |
| HILIC NEGATIVE ION MODE | tumor-enzalutamide-4-02 | Treatment:Enzalutamide | Technical Replicate (Region of Tumor):2 | Peak Area |
| HILIC NEGATIVE ION MODE | tumor-enzalutamide-5-02 | Treatment:Enzalutamide | Technical Replicate (Region of Tumor):2 | Peak Area |
| HILIC NEGATIVE ION MODE | tumor-veh-1-01 | Treatment:Vehicle | Technical Replicate (Region of Tumor):1 | Peak Area |
| HILIC NEGATIVE ION MODE | tumor-veh-2-01 | Treatment:Vehicle | Technical Replicate (Region of Tumor):1 | Peak Area |
| HILIC NEGATIVE ION MODE | tumor-veh-3-01 | Treatment:Vehicle | Technical Replicate (Region of Tumor):1 | Peak Area |
| HILIC NEGATIVE ION MODE | tumor-veh-1-02 | Treatment:Vehicle | Technical Replicate (Region of Tumor):2 | Peak Area |
| HILIC NEGATIVE ION MODE | tumor-veh-2-02 | Treatment:Vehicle | Technical Replicate (Region of Tumor):2 | Peak Area |
| HILIC NEGATIVE ION MODE | tumor-veh-3-02 | Treatment:Vehicle | Technical Replicate (Region of Tumor):2 | Peak Area |
Return to study ST002852 main page
Download data matrix(MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancer HILIC POSITIVE ION MODE)
Download data matrix(MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancer HILIC NEGATIVE ION MODE)
- Metabolomics Workbench
|